Zobrazeno 1 - 10
of 275
pro vyhledávání: '"H. G. Prentice"'
Autor:
Martin S. Tallman, Peter H. Wiernik, Ian M. Franklin, Hillard J. Lazarus, H. G. Prentice, Alan Kenneth Burnett, Mark R. Litzow, G Harrison, Sue Richards, R Chopra, Jill Durrant, Jacob M. Rowe, Anthony H. Goldstone
In 1993 we initiated an International study in newly diagnosed adults with ALL (aged 15 to 55 years). 1508 eligible patients were entered before 31st October 2003 and achieved a complete remission (CR) rate of 91%. 551 patients underwent transplant i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b59e00279fc90a1decf9fbe8e3e974c0
https://ora.ox.ac.uk/objects/uuid:4a0bc2cb-4a88-43cb-850c-aff606b181e7
https://ora.ox.ac.uk/objects/uuid:4a0bc2cb-4a88-43cb-850c-aff606b181e7
Publikováno v:
Hematology (Amsterdam, Netherlands). 2(3)
The role of the immune response in control and erradication of leukaemia remains controversial but there is increasing evidence that the principal mechanism of cure after intensive chemotherapy and allogeneic BMT is immune mediated. This is evidenced
Autor:
Jane F. Apperley, P. J. Gravett, George Janossy, K. Ivory, D. Wardle, JohnM. Goldman, Almalina Bacigalupo, A. A. G. Robertson, H. G. Prentice, I. Mcvickei, Hilary A. Blacklock, C. Pearson, Christopher M. Reid, I. M. Hann, M. J. M. L. Gilmore, A. V. Hoffbrand, M. Alcorn, Alan Kenneth Burnett, J. Lord, J. Patterson, D. Skeggs, Malcolm K. Brenner, H. Morgan, John G. Gribben
Publikováno v:
British Journal of Haematology. 63:221-230
Bone marrow graft rejection following HLA-matched bone marrow transplantation (BMT) for leukaemia has been a rare problem. However, with the introduction of T-lymphocyte depleted BMT, graft rejection is recognized as a new complication. At the Royal
Autor:
R. L. Powles, Jennifer Byrne, Rajesh Chopra, S Koblinger, Bhawna Sirohi, H. G. Prentice, Michael N. Potter, Nigel H. Russell
Publikováno v:
Bone Marrow Transplantation. 38:47-51
This open-label, dose-escalation study assessed the maximum tolerated dose (MTD) of the new antifungal micafungin in patients undergoing haematopoietic stem cell transplantation (HSCT). Participants received 3, 4, 6 or 8 mg/kg/day micafungin intraven
Autor:
Shila Seaton, H. G. Prentice, J McLaughlin, P J Paterson, M Potter, Timothy D. McHugh, C.C. Kibbler
Publikováno v:
Clinical Infectious Diseases. 42:51-56
Background. Invasive fungal infections due to less-common molds are an increasing problem, and accurate diagnosis is difficult.Methods. We used our previously established molecular method, which allows species identification of molds in histological
Autor:
Charles Craddock, Antonio Pagliuca, Jennifer Byrne, Ghulam J. Mufti, Stephen Devereux, Michael Potter, Grant McQuaker, Andrew P. Haynes, Prem Mahendra, Nigel H. Russell, Rowena D. Faulkner, Aloysius Ho, H G Prentice, John Liu Yin
Publikováno v:
Blood. 103:428-434
We report the outcomes of reduced-intensity allogeneic stem cell transplantation using BEAM-alemtuzumab conditioning (carmustine, etoposide, cytosine arabinoside, melphalan, and alemtuzumab 10 mg/d on days –5 to –1) in 6 United Kingdom transplant
Autor:
Mark Ethell, A Guimarães, P R Fallen, J A Madrigal, H. G. Prentice, PJ Travers, Michael Potter, L McGreavey
Publikováno v:
Bone Marrow Transplantation. 32:1001-1014
The factors affecting T cell reconstitution post haematopoietic cell transplantation (HCT) are not well characterised. We carried out a longitudinal analysis of T cell reconstitution in 32 HCT recipients during the first 12 months post transplant. We
Publikováno v:
Journal of Antimicrobial Chemotherapy. 52:873-876
Objectives To determine whether treatment failure in invasive aspergillosis (IA) is the result of resistance of Aspergillus spp. isolates to amphotericin B. Methods Six Aspergillus fumigatus and six Aspergillus flavus isolates cultured from deep tiss
Autor:
H. G. Prentice
Publikováno v:
Supportive Care in Cancer. 11:501-508
Cancer patients undergoing bone marrow transplantation (BMT) experience severe nausea and vomiting associated with high-dose chemotherapy agents; these emetic symptoms are compounded by total body irradiation used in many conditioning regimens. This
Autor:
F. E. Chen, J A Madrigal, Michael N. Potter, Mark W. Lowdell, R F Duarte, H. G. Prentice, M L Lamana
Publikováno v:
Gene Therapy. 9:1359-1368
The immune function of retrovirus-mediated gene modified (GM) T cells is critical for a beneficial effect to follow their adoptive transfer into patients. Recent clinical data show that GM T cells expanded with PHA have reduced function in vivo. Howe